Bhushan Bharat, Borude Prachi, Edwards Genea, Walesky Chad, Cleveland Joshua, Li Feng, Ma Xiaochao, Apte Udayan
Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas.
Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas.
Am J Pathol. 2013 Nov;183(5):1518-1526. doi: 10.1016/j.ajpath.2013.07.012. Epub 2013 Sep 3.
Bile acids play a critical role in liver injury and regeneration, but their role in acetaminophen (APAP)-induced liver injury is not known. We tested the effect of bile acid modulation on APAP hepatotoxicity using C57BL/6 mice, which were fed a normal diet, a 2% cholestyramine (CSA)-containing diet for bile acid depletion, or a 0.2% cholic acid (CA)-containing diet for 1 week before treatment with 400 mg/kg APAP. CSA-mediated bile acid depletion resulted in significantly higher liver injury and delayed regeneration after APAP treatment. In contrast, 0.2% CA supplementation in the diet resulted in a moderate delay in progression of liver injury and significantly higher liver regeneration after APAP treatment. Either CSA-mediated bile acid depletion or CA supplementation did not affect hepatic CYP2E1 levels or glutathione depletion after APAP treatment. CSA-fed mice exhibited significantly higher activation of c-Jun N-terminal protein kinases and a significant decrease in intestinal fibroblast growth factor 15 mRNA after APAP treatment. In contrast, mice fed a 0.2% CA diet had significantly lower c-Jun N-terminal protein kinase activation and 12-fold higher fibroblast growth factor 15 mRNA in the intestines. Liver regeneration after APAP treatment was significantly faster in CA diet-fed mice after APAP administration secondary to rapid cyclin D1 induction. Taken together, these data indicate that bile acids play a critical role in both initiation and recovery of APAP-induced liver injury.
胆汁酸在肝损伤和肝再生中起关键作用,但其在对乙酰氨基酚(APAP)诱导的肝损伤中的作用尚不清楚。我们使用C57BL/6小鼠测试了胆汁酸调节对APAP肝毒性的影响,这些小鼠在接受400 mg/kg APAP治疗前1周,分别喂食正常饮食、含2%消胆胺(CSA)的饮食以消耗胆汁酸,或含0.2%胆酸(CA)的饮食。CSA介导的胆汁酸消耗导致APAP治疗后肝损伤显著加重且再生延迟。相比之下,饮食中补充0.2% CA导致肝损伤进展适度延迟,且APAP治疗后肝再生显著增强。CSA介导的胆汁酸消耗或CA补充均不影响APAP治疗后肝脏CYP2E1水平或谷胱甘肽消耗。喂食CSA的小鼠在APAP治疗后c-Jun氨基末端蛋白激酶的激活显著增强,肠道成纤维细胞生长因子15 mRNA显著减少。相比之下,喂食0.2% CA饮食的小鼠c-Jun氨基末端蛋白激酶激活显著降低,肠道中成纤维细胞生长因子15 mRNA高12倍。由于细胞周期蛋白D1快速诱导,APAP给药后,喂食CA饮食的小鼠APAP治疗后的肝再生明显更快。综上所述,这些数据表明胆汁酸在APAP诱导的肝损伤的起始和恢复中均起关键作用。